Overview

An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The current study would prospectively evaluate the dosing requirements, efficacy and safety of clevidipine for controlled hypotension during spinal surgery in the pediatric population. As the investigators currently have projects underway which include those patients having scoliosis surgery for idiopathic scoliosis, this trial would include only those undergoing scoliosis surgery for neuromuscular disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Nationwide Children's Hospital
Treatments:
Clevidipine